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ABSTRACT   
The aim of this study was to describe the seminal, histomorphological and hormonal 
effects of the oral indenopyridine RTI-4587-073(l) on the cat testicle. Side effects were 
also recorded.  Sixty testicles of adult cats that had been treated (d 0) with RTI-4587-
073(l) 12.5 mg/kg PO and randomly hemi-orchiectomized twice on: day -14 (n = 8), 6 h 













= 6) or day 42 (n = 6) were studied. Before each hemi-orchiectomy, fecal samples for 
testosterone (T) measurement were collected and the testes were grossly and examined 
using ultrasonography. The indenopyridine treatment did not induce changes in testicular 
weight (P>0.1), volume (P>0.1), echostructure, gonadosomatic index (P>0.1), fecal T 
concentrations (P>0.1), nor clinical side effects.  A severe disorganization of the 
cytoarchitecture of the seminiferous epithelium, sloughed cells and fluid, were observed 
in the 6 h samples up to a maximum at  24 h. Tubular diameter (P<0.01) increased twice, 
during the first 24 h and on d 35. Germinal epithelium was of minimal height on d 14 and 
rapidly recovered thereafter. After treatment, there was a significant decrease in the 
volume of all the seminiferous cell components, except spermatogonia. Values for all 
histotological variables were normal by the end of the study. It was concluded that 
treatment with RTI-4587-073(l) severely disrupted spermatogenesis during the first 24 h 
after treatment, however, there was a returning to normality in approximately one 
spermatic cycle without side effects. 
 






Domestic felids (Felis catus) are extremely prolific breeders mating from early 
puberty to the time of death and, if maintained indoors or at latitudes higher than 35º, 
throughout the year (Faya et al., 2011). Thus, contraception - reversible reproduction 













mammalian species, development of feline contraceptives is mainly focused on females 
and progestins are commonly used. Sometimes use of progestins lead to severe 
reproductive and general health side effects (Munson, 2006). Although steroidal and non-
steroidal approaches have been assessed in males, controlling spermatogenesis is more 
complex than preventing ovulation in females. Furthermore, with use of most male 
contraceptive protocols there is a variable lag time to achieve azoospermia as well as an 
unpredictable return to fertility (Bowen, 2008). Safe, rapid and efficient pharmaceutical 
compounds are, therefore, still needed to temporally control the undesired reproduction 
in male felids. If tom cats were rendered temporarily sterile, female reproductive health 
could also be enhanced.  
The group of indenopyridine derivatives, which were originally developed as 
antihistamine drugs, has anti-spermatogenic effects in rats (Hodel and Suter, 1978), 
stallions (Pozor et al., 2013) and dogs (Chang et al., 2002) without overt side effects, 
toxicity nor mutagenic potential (Fail et al., 2000; Mruk et al., 2008). Results from studies 
in laboratory animals indicate that the primary target of indenopyridines is the Sertoli cell, 
resulting in disruption of Sertoli - germ cell adhesion (Hild et al., 2001; 2007b; Koduri et 
al., 2008).  
While in monkeys indenopyridines induced reversible severe 
oligoasthenozoospermia (Hild et al., 2007a), however, irreversible infertility occurred in 
rats as a result of this treatment (Hild et al., 2001).  In horses and dogs, treatment with 
indenopyridines induced a rapid (few days) and transient inhibition of spermatogenesis 
with an increased number of immature germ cells in ejaculates (Hodel and Suter, 1978; 
Chang et al., 2002; Pozor et al., 2013, 2014). Histologically the seminiferous tubuli 
appeared devoid of spermatids and spermatocytes (Pozor et al., 2013). The common 













for non-steroidal, oral male contraception in felids, however, there is nothing known 
about effects, reversibility and tolerance of cats when there is administration of these 
compounds (Munson, 2006). 
The compound RTI-4587-073, formerly termed CDB-4022, is a new indenopyridine 
derivative, which is a mixture of L and D-isomers. The L-isomer has marked anti-
spermatogenic activity (Pozor et al., 2013) and, therefore, was selected for the present 
feline trial. Thus, the aim of the present study was to describe the ultrasonographic, 
histomorphological and hormonal effects of oral indenopyridine RTI-4587-073(l) in the 
cat testicle. Secondly, some epididymal semen characteristics and clinical side effects of 
the drug were also recorded in the treated cats.  
 
 
2. Materials and methods 
 
2.1. Experimental protocol  
Sixty testicles of 1.5 to 5 years old, domestic short- hair, fertile cats were included 
in this study. The toms had been born in our Institutional Colony and there was an 
imposed 14 h photoperiod in three 4 x 4 m enriched rooms, with animals being fed a 
commercial food and water being available ad libitum. The animals were treated (day 0) 
with RTI-4587-073(l) at a 12.5 mg/kg dose orally and randomly hemi-orchiectomized 
twice on: day -14 (n = 8), 6 hours (n = 6), 12 hours (n = 8), day 1 (n = 6), day 7 (n = 8), 
day 14 (n = 6), day 21 (n = 6), day 35 (n = 6) or day 42 (n = 6). The calculated dose was 
dissolved in 2 cc of saline and administered by a naso-esophageal tube after mild sedation. 













et al., 2001; Pozor et al., 2013) and results from some preliminary studies before 
conducting the present study with cats. 
Before each hemi-orchidectomy, fecal samples were collected and the testes were 
examined grossly and ultrasonographically in a way that each animal had two random 
evaluation time points on the days of surgeries. The eventual appearance of clinical side 
effects was also recorded in all the animals. This study was reviewed and approved by 
the Animal Care and Use Committee of the Veterinary School of the National University 
of La Plata and all experiments were conducted considering the guidelines established in 
The Guide for The Care and Use of Laboratory Animals, USA. 
 
2.2. Ultrasonic evaluations 
Ultrasonic examinations of the testes were undertaken by a single experienced 
evaluator using a real time B-mode ultrasonic machine (Toshiba Nemio XG, Japón) with 
a 14 MHz lineal transducer. All machine settings were established at the first examination 
based on the most distinct image quality and remained unaltered for all remaining 
examinations. Acoustic gel was applied to the transducer and coupled directly to the 
clipped scrotum with minimum pressure to obtain the images. The testes were imaged in 
the sagittal and transverse planes. Testicular dimensions were obtained from frozen 
images, using the ultrasonic calipers and the total testicular volume was calculated as 
described by Linn et al. (2009). Ecogenicity and homogeneity of the parenchyma were 
also assessed at each time point.  
 
2.3. Fecal collection, extraction and hormone determinations  
Fecal samples were collected at the time points of hemi-orchidectomies 













Fecal steroids were extracted using the methods described by Faya et al. (2013) and T 
(ng/ml) was quantified using a electrochemiluminescence immunoassay (Elecsys Testo 
II, Roche Diagnostics, Mannheim, Germany). Inter- and intra-assay coefficients of 
variation of the assays were < 10% and sensitivity was 0.025 ng/mL. All fecal data were 
expressed on a wet-weight basis  
 
2.4. Hemiorchidectomies  
All the cats were randomly hemi-orchidectomized twice using the procedures 
described by García Romero et al. (2012) in a way that a total of 60 testes were obtained. 
Briefly, the animals were pre-medicated with atropine sulfate, (Atropine Sulfate, John 
Martin; 0.04 mg/kg SC), acepromazine maleate (Acedan, Holliday; 0.03 mg/ kg SC), and 
butorphanol (Torbutol Plus, Fort Dodge; 0.2 mg/kg IM), anesthesia was induced with 
sodium thiopental (Pentovet TM, Richmond; 8 mg/kg IV) in all of the animals. After the 
cats were endotracheally intubated, anesthesia was maintained with isoflurane and 
oxygen in a closed system.  Each testis was removed through a longitudinal midscrotal 
incision using sterile surgical procedures and a closed tunic technique, and subsequently 
the spermatic cord was ligated with 3.0 vicryl before transection. After surgery, 
ketoprofen (Ketofen®, Fort Dodge; 1 mg/kg) was administered SC (once) and then orally 
every 24 h for 4 additional days. All the cats were subsequently placed for adoption. 
 
2.5.Gross and histological examination of the testes 
Immediately after surgical removal, the testes were measured (length, width and 
depth; cm) and weighed (g) and gonadosomatic index (%; Franca and Godinho, 2003) 













Spermatozoa morphology was evaluated using a Giemsa stain with 1000X magnification 
using bright field microscopy (Valiente et al., 2014).  
The testes, were sectioned longitudinally, placed in Bouin’s fixative for 12 h and 
the solution was subsequently changed to alcohol 70% and tissues were processed 
routinely with paraffin embedding.  After processing, 5 µm serial sections were cut, 
mounted on slides, dyed, deparaffinized in xylene, rehydrated in graded ethanol solutions 
and stained with hematoxylin and eosin. Histological images were obtained using a 
microscope (Olympus BX50; 10X and 40X) with an attached video camera (Sony DXC 
151) and digitalized in a 24 bit true color TIFF format. Twenty tubular profiles, which 
were round or nearly round, were chosen randomly and measured for each animal. The 
tubular diameter of seminiferous tubules (µm) and the germinal epithelium height (µm) 
were measured using planimetry (Image Pro Plus, Media Cybernetics, Silver Spring, MA, 
USA). The volume (cm3) of the different testicular tissue components was determined by 
light microscopy using a 441-intersection grid placed on 940 magnification. For this, 15 
fields were chosen randomly (6615 points) and scored for each animal. Points were 
classified as one of the following: spermatogonia, primary and secondary spermatocytes, 
round spermatids, elongated spermatids, spermatozoa, Sertoli and Leydig cells, 
intertubular compartment, and cellular debris.  
 
2.6. Statistical analysis 
Normality of distribution of results was tested using a Shapiro - Wilk normality 
test. All hormonal, gross and microscopic variables were compared among time points 
using the Kruskall-Wallis test followed by use of a Dunn’s multiple comparisons test. In 
all the cases, descriptive data were expressed as mean ± SEM and P values <0.05 were 















3. Results  
Neither gross testicular variables including weight (P>0.1), volume (P>0.1) and 
gonadosomatic index (P>0.1) nor body weight (P>0.1) were affected by RTI-4587-073(l) 
treatment at the different evaluation time points (Table 1). Although epididymal 
spermatozoa morphology was normal in all the cases, giant multinucleated cells appeared 
in the semen samples during the first 24 h after treatment (Fig 1). 
Histological testicular structure was normal on day -14 (Fig 2;A) and a severe 
disorganization of the cy-architecture of the seminiferous epithelium was observed in the 
samples collected at the 6 h time point reaching a maximum impairment at 24 h, with the 
presence of vacuolization, immature germ and multinucleated cells as well as intra-
tubular fluid (Fig 2; B). During the first 24 h after treatment, several seminiferous tubules 
were in the process of sloughing or had already sloughed material within the lumen 
occluding the tubules along with the fluid and cellular detritus (P<0.01; Fig 2; C and D). 
These abnormalities gradually disappeared by the end of the study (Fig 2, F, H, I) and 
there was no evidence of abnormalities through the echo-structure evaluations which was 
normal at all time points (Mattoon and Nyland, 1995). 
Seminiferous tubular diameter (P<0.01; Fig 3, Inset) increased as the interstitium 
decreased (P<0.01) during the first 24 h with the greatest effects in these regards 
occurring on d 35. The size of the tubular diameter tended to return to the original size 
before treatments were administered by the end of the study. 
Germinal epithelium height could not be measured during the first 24 h after treatment 
due to the major disorganization of its cyto-architecture (Fig 3). This epithelium was of a 













thereafter, it maintained at the same height (Fig 3). Although the volume occupied by 
spermatogonia did not vary during the study (P>0.1) the volume occupied by primary 
spermatocytes decreased during this period (P>0.01). This decrease was even more 
marked in the case of secondary spermatocytes (P<0.01; Fig 4), round (P>0.01) and 
elongated (P<0.01; Fig 4 Inset) spermatids as well as luminal spermatozoa (P<0.01) 
which reappeared shortly before the end of the study on day 42. Conversely, the volume 
of tissue occupied by Sertoli cells increased 24 h after treatment and subsequently 
decreased up to day 14 when it began to return to a volume that existed pretreatment 
(P<0.01). 
Although, the volume occupied by Leydig cells was less at all the post treatment 
observations than it was before treatments were administered (P>0.01), fecal T 




Widespread use of contraceptives has been limited in male felids as a result of safety 
concerns and the lack of effective options. The indenopyridines, however, have 
antispermatogenic effects in several mammals. There are, however, species differences 
in responses which indicates the need for the biological effects of this compound to be 
assessed in species such as cats if there is going to the use in those species. To the best of 
the authors´ knowledge, this is the first report that describes the effects of indenopyridines 
in cats. 
Consistent with findings in rats (Hild et al., 2001; Koduri et al., 2008) and monkeys 
(Hild et al., 2007a) but different from those in horses (Pozor et al., 2014), T concentrations 













suppression of T and, therefore, libido would have been desirable in domestic cats, T 
dependent changes in behavior and phenotype are a disadvantage for wild, endangered 
felids.  Testicular volume occupied by Leydig cells was less as compared to volumes pre-
treatment in all post-treatment observations in the present study. It should be borne in 
mind that in the present study, fecal determinations could have masked transient serum T 
variations that could have been present in blood samples. Consistent with results in horse 
studies with the same pharmacological protocol (Pozor et al., 2014), total testicular 
volume did not change during the period that the present study was conducted.  
The rapidity of histological effects after treatment with RTI-4587-073(l) in the present 
study was one of the most marked findings when applying the antispermatogenic 
protocol. Similar rapid effects of treatment with RTI-4587-073(l) on testicular tissue were 
previously described in monkeys, horses, dogs and rats (Chang et al., 2002; Hild et al., 
2001; 2007a; Pozor et al., 2014). 
The seminiferous epithelium vacuolization and sloughing into the tubular lumen 
causing severe tubular disorganization is a common histopathological observation 
associated with Sertoli cell injury after exposure to testicular toxicants (Vidal and 
Whitney, 2014; Johnson, 2015). The multinucleated giant cells found both in the 
epithelium and semen are thought to arise from fusion of degenerate spermatids with 
abnormal intercellular bridges (Vidal and Whitney, 2014). This kind of cells was also 
previously observed in rats, horses and dogs treated with bisdiamines (Hild et al., 2001; 
Chang et al., 2002; Pozor et al., 2013).  
Specifically, indenopyridines alter Sertoli cells leading to a massive germ cell loss 
(Koduri et al., 2008). As Sertoli cell junctions are an essential component of the blood-
testis barrier required for normal spermatogenesis these sites have been considered a 













injury in Sertoli cells could, not only, explain the early increase in the volume of these 
cells but also the augmentation of the whole tubular diameter associated with fluid 
production on Day 1 after RTI-4587-073(l) treatment (Vidal and Whitney, 2014).  
As expected, in the presence of these severe histological findings almost all cellular 
components of the germinal epithelium were affected by the indenopyridine treatment.  
Importantly, the major decrease in numbers of germinal cells occurred because there were 
fewer spermatocytes and spermatids after treatment with RTI-4587-073(l).  
Before the treatment on day -14, all characteristics for histomorphometric variables 
were similar to those previously described for the species (Franca and Godinho, 2003; 
Siemieniuch and Wocławek-Potocka, 2007). The early increase in the seminiferous 
tubule diameter in the present study has previously thought to be associated with the 
tubular fluid production after toxicant administration that affected Sertoli cell functions 
(Vidal and Whitney, 2014). The late augmentation of this diameter on day 35 could be 
explained as a rebound recovery of spermatogenesis at that time point (Meisami et al., 
1994).  
The height of the germinal epithelium rapidly decreased to two layers of cells on day 
14, however, there was recovery with values for germinal epithelial height being greater 
than the pretreatment values 1 week after treatment. With use of the pharmacological 
protocol in the present study, spermatogenesis recovery was possible because of the lack 
of an effect on spermatogonia throughout the study period. Treatment with 
indenopyridines have resulted in variable outcomes with there being either a reversible 
(Chang et al., 2002; Hild et al., 2007a; Pozor et al., 2013) or irreversible (Hild et al., 2001) 
effect on fertility, depending on the species. In the domestic cats of the present study, 
there was a reversible effect of this compound on the germinal epithelium during a time 













Godinho, 2003). Similarly, in indenopyridine treated horses and dogs, reversible 
spermatogenesis was noted 6 and 7 weeks after  administration of this compound, 
respectively (Chang et al., 2002; Pozor et al., 2014). 
Considering the rapid and severe histological changes as well as the reversibility of 
spermatogenesis it would be of interest in the future to test, in vivo,  fertility during the 
time when there were the greatest indenopyridine effects after treatment and also after 
recovery so that there could be single- or serial-dose protocols developed for felids. 
Consistent with findings in rodents (Hild et al., 2001) there were no observable 
adverse effects such as body weight loss or digestive problems in the treated animals of 
the present study, suggesting that this compound had no general toxicity.  
In conclusion, treatment with RTI-4587-073(l) provides for a rapid, effective, 
reversible and safe non-steroid antispermatogenic oral protocol for male cat contraception 
because this treatment severely disrupts spermatogenesis during the first 24 h after 
treatment with there being initiation of spermatogenesis that results in the presence of 
normal sperm in the tail of the epididymis after a period that equates approximately to 
one spermatic cycle. Further refinement, including the study of effects of repeated doses 
and surveillance for long-term adverse effects, of these indenopyridine derivatives should 
occur before field implementations are widely recommended.  
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Fig. 1. Giant multinucleated cell (Giemsa stain, 1000X) in epididymal sperm during the 





Fig. 2. Seminiferous tubule characteristics of cats at different time points subsequent to 
RTI-4587-073(l) treatment:  -14 (A), 6 hours (B), 12 hours (C), day 1 (D), day 7 (E), day 
14 (F), day 21 (G), day 35 (H) and day 42 (I); All sections were stained with hematoxylin 
and eosin (40X)  
Notice normal germinal epithelium and spermatozoa at the luminal border (A), fluid in 
the lumen of a seminiferous tubule (B), seminiferous epithelium sloughing into the lumen 
with a giant multinucleated cell in the center (C), severe disorganization of the 
seminiferous epithelium with occluding detritus filling the lumen (D), epithelium 
sloughing is finishing and some vacuoles are appearing, luminal detritus is diminishing 
(E), thin germinal epithelium  with frayed luminal border  and  some detritus  in the lumen 













recovered  germinal epithelium height with some vacuoles (H), fully recovered germinal 








Fig. 3. Testicular germinal epithelium height and tubular diameter (mean ± SEM; Inset) 
of the cats treated with RTI-4587-073(l); Germinal epithelium height could not be 
measured during the first 24 hours after treatment; Asterisks indicate differences P < 0.05 
 
Fig.  4. Secondary spermatocytes and elongated spermatids (mean ± SEM; Inset) of cats 
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Morphometric data of the 30 male cats administered (d 0) a single PO dose of 12.5 mg/kg 
RTI-4587-073(l) and randomly hemi-orchiectomized twice on: day -14 (n = 8), 6 hours 
(n = 6), 12 hours (n = 8), day 1 (n = 6), day 7 (n = 8), day 14 (n = 6), day 21 (n = 6), day 
35 (n = 6) or day 42 (n = 6) 
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